ClinVar Miner

Submissions for variant NM_000249.3(MLH1):c.-14C>T (rs730881744)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Color RCV000776169 SCV000911259 likely benign Hereditary cancer-predisposing syndrome 2016-11-15 criteria provided, single submitter clinical testing
GeneDx RCV000160546 SCV000211124 uncertain significance not provided 2014-06-25 criteria provided, single submitter clinical testing This variant is denoted MLH1 c.-14C>T, and describes a nucleotide substitution 14 base pairs upstream of the MLH1 ATG translational start site in the 5' translated region (UTR). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. Although this variant does not appear to affect the start codon or the Kozak translational consensus sequence, constitutional epigenetic silencing of MLH1 has been suggested as an alternate mechanism responsible for Lynch syndrome and variants located within the 5' UTR have been shown to result in allele specific promoter methylation and subsequent transcriptional silencing (Hitchins 2011, Ward 2013). This variant was not observed in approximately 6,500 individuals of European or African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The nucleotide which is altered, a cysteine (C) at base -14, is only moderately conserved across species. At this time, it is unclear whether MLH1 c.-14C>T is pathogenic or benign. We consider it to be a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.